PIMs+

2019 PIMs+™

This list of Potentially Inappropriate Medicines (PIMs+™) has been developed to assist in optimal medication management and improved health outcomes for all older adults.  PIMs+™ is the result of a multidisciplinary collaborative effort of TaperMD, Department of Family Medicine McMaster University, and the American Society of Consultant Pharmacists. The PIMs+™ is updated on a continuous basis and is currently in beta testing and a a collaborative team is reviewing the content. While we are in our beta version, the 2019 PIMs+™ is open to all at no cost.

We welcome your feedback on how to improve this resource.

wdt_IDBrand(s)GenericClassPIMs+
1CangrelorAntithrombotics

Avoid in patients with late-stage dementia.

2CaplacizumabAntithrombotics

Avoid in patients with late-stage dementia.

3CilostazolAntithrombotics

Avoid in patients with late-stage dementia.

4ClopidogrelAntithrombotics

Avoid in patients with late-stage dementia.

5PrasugrelAntithrombotics

Avoid in patients with late-stage dementia.

6TicagrelorAntithrombotics

Avoid in patients with late-stage dementia.

7TiclopidineAntithrombotics

Avoid in patients with late-stage dementia.

8DipyridamoleAntithrombotics

Avoid in patients with late-stage dementia.

ACB: Score 1

9CholestyramineBile acid sequestrants

Avoid in patients with mid or late-stage dementia.

10ColesevelamBile acid sequestrants

Avoid in patients with mid or late-stage dementia.

GenericClass